English
Home > Products > Tazobactam acid intermediate

China Tazobactam acid intermediate Factory

Our well-equipped facilities and excellent quality control throughout all stages of production enables us to guarantee total customer satisfaction for Tazobactam acid intermediate,CAS NO 122661-93-2,CAS NO 125949-72-6,122661-93-2,125949-72-6, We have experienced manufacturing facilities with more than 100 employees. So we can guarantee short lead time and quality assurance.
Tazobactam acid intermediate, We pay high attention to customer service, and cherish every customer. We now have maintained a strong reputation in the industry for many years. We've been honest and work on building a long-term relationship with our customers.

Related Products

Hot Products

  • 4-Butylresorcinol

    4-Butylresorcinol

    Product Name:4-Butylresorcinol
    Molecular Formula:C10H14O2
    Molecular Weight;166.22
    CAS Registry Number;18979-61-8
  • (-)-Epigallocatechin gallate

    (-)-Epigallocatechin gallate

    Product Name:(-)-Epigallocatechin gallate
    Molecular Formula:C22H18O11
    Molecular Weight:458.37
    CAS Registry Number:989-51-5
  • 18-Crown-6

    18-Crown-6

    Product Name:18-Crown-6
    Molecular Formula:C12H24O6
    Molecular Weight:264.32
    CAS Registry Number:17455-13-9
  • Ziprasidone hydrochloride monohydrate

    Ziprasidone hydrochloride monohydrate

    Product Name:Ziprasidone hydrochloride monohydrate
    Molecular Formula:C21H24Cl2N4O2S
    Molecular Weight;467.41
    CAS Registry Number;138982-67-9
  • Vonoprazan

    Vonoprazan

    Product ​Name:Vonoprazan
    Molecular Weight:345.39
    CAS NO:881681-00-1
    Usage:Vonoprazan Intermediates
  • 4-Methoxy-2-oxo-1,2-dihydro-pyridine-3-carbonitrile

    4-Methoxy-2-oxo-1,2-dihydro-pyridine-3-carbonitrile

    Product Name:4-Methoxy-2-oxo-1,2-dihydro-pyridine-3-carbonitrile
    Molecular Formula:C7H6N2O2
    Molecular Weight:150.13
    CAS Registry Number:21642-98-8
  • Related Blog
  • Reviews

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • What is Coenzyme Q10 CAS NO.303-98-0

    Coenzyme Q10 (CAS NO.303-98-0 ) is a fat-soluble antioxidant, which can activate the nutrition of human cells and cellular energy, and has the functions of improving human immunity, enhancing antioxidation, delaying ageing and enhancing human vitality.

  • What are the raw materials required for pharmaceutical industry?

    Pharmaceutical industry has a lot of constraints and specialties which make it stand on a completely differents scale than any other industries. Being closely related to the medical field and also complementary to it, the pharmaceutical industry needs utmost care and precision in each and every aspect of the field ranging from collecting the raw materials to getting the final product ready for supply in the market.

  • Why API manufacturing companies almostly in China?

    In the chemical API industry, developed countries such as the United States and Europe occupy a dominant position in the field of patented APIs with high added value by virtue of their advantages in research and development, production technology, and intellectual property protection...

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept